DIABETOLOGY / LETTER TO THE EDITOR
Should SGLT2 inhibitors be prescribed in all diabetic type 2 patients?
| 1 | Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy |
| 2 | Catholic University of the Sacred Heart, Rome, Italy |
| 3 | Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy |
| 4 | Mediterranea Cardiocentro, Naples, Italy |
| 5 | Heart Institute, 47-83 Boulevard de l’Hôpital, ACTION Study Group-CHU Pitié-Salpétrière Paris, France |
| 6 | Collège National des Cardiologues Français (CNCF), Paris, France |
CORRESPONDING AUTHOR
Submission date: 2022-11-13
Final revision date: 2023-01-17
Acceptance date: 2023-01-28
Online publication date: 2023-02-03
Publication date: 2023-03-01
Arch Med Sci 2023;19(2):528–531
TOPICS
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.